RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CSL Stock

CSL Net Income 2024

CSL Net Income

2.64 B USD

Ticker

CSL.AX

ISIN

AU000000CSL8

WKN

890952

In 2024, CSL's profit amounted to 2.64 B USD, a 20.42% increase from the 2.19 B USD profit recorded in the previous year.

The CSL Net Income history

YEARNET INCOME (undefined USD)
2030e5.79
2029e5.4
2028e4.95
2027e4.33
2026e3.83
2025e3.3
20242.64
20232.19
20222.25
20212.38
20202.1
20191.92
20181.73
20171.34
20161.24
20151.38
20141.31
20131.22
20121.01
20110.94
20100.93
20090.84
20080.63
20070.42
20060.09
20050.41

CSL Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CSL, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CSL from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CSL’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CSL. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CSL’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CSL’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CSL’s growth potential.

CSL Revenue, EBIT and net profit per share

DateCSL RevenueCSL EBITCSL Net Income
2030e23.53 B undefined7.67 B undefined5.79 B undefined
2029e22.21 B undefined7.15 B undefined5.4 B undefined
2028e20.04 B undefined6.59 B undefined4.95 B undefined
2027e18.14 B undefined6.05 B undefined4.33 B undefined
2026e17.07 B undefined5.47 B undefined3.83 B undefined
2025e15.92 B undefined4.78 B undefined3.3 B undefined
202414.8 B undefined3.81 B undefined2.64 B undefined
202313.31 B undefined3.25 B undefined2.19 B undefined
202210.56 B undefined2.93 B undefined2.25 B undefined
202110.31 B undefined3.13 B undefined2.38 B undefined
20209.15 B undefined2.72 B undefined2.1 B undefined
20198.54 B undefined2.5 B undefined1.92 B undefined
20187.92 B undefined2.38 B undefined1.73 B undefined
20176.92 B undefined1.77 B undefined1.34 B undefined
20166.12 B undefined1.44 B undefined1.24 B undefined
20155.63 B undefined1.77 B undefined1.38 B undefined
20145.52 B undefined1.66 B undefined1.31 B undefined
20135.13 B undefined1.52 B undefined1.22 B undefined
20124.77 B undefined1.3 B undefined1.01 B undefined
20114.26 B undefined1.2 B undefined936.5 M undefined
20104.06 B undefined1.23 B undefined926.7 M undefined
20093.69 B undefined1.05 B undefined842.2 M undefined
20083.4 B undefined896.3 M undefined627.9 M undefined
20072.6 B undefined643 M undefined423.3 M undefined
20062.17 B undefined158.4 M undefined87.7 M undefined
20052.45 B undefined648.4 M undefined411 M undefined

CSL stock margins

The CSL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CSL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CSL.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CSL's sales revenue. A higher gross margin percentage indicates that the CSL retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CSL's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CSL's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CSL's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CSL. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CSL's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CSL Margin History

CSL Gross marginCSL Profit marginCSL EBIT marginCSL Profit margin
2030e51.83 %32.59 %24.61 %
2029e51.83 %32.19 %24.33 %
2028e51.83 %32.9 %24.69 %
2027e51.83 %33.38 %23.88 %
2026e51.83 %32.01 %22.46 %
2025e51.83 %30 %20.71 %
202451.83 %25.76 %17.85 %
202351.28 %24.44 %16.48 %
202254.27 %27.72 %21.35 %
202156.68 %30.36 %23.04 %
202057.11 %29.69 %22.98 %
201955.95 %29.33 %22.47 %
201855.38 %30.07 %21.84 %
201751.94 %25.55 %19.32 %
201650.08 %23.51 %20.32 %
201553.7 %31.51 %24.5 %
201452.86 %30 %23.66 %
201353.38 %29.54 %23.71 %
201250.39 %27.16 %21.25 %
201150.74 %28.27 %21.97 %
201052.59 %30.32 %22.84 %
200952.21 %28.51 %22.82 %
200849.17 %26.4 %18.49 %
200747.56 %24.73 %16.28 %
200641.39 %7.3 %4.04 %
200548.15 %26.51 %16.8 %

CSL Aktienanalyse

What does CSL do?

CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding CSL's Profit Margins

The profit margins of CSL represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of CSL's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating CSL's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

CSL's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When CSL’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about CSL stock

How much profit has CSL made this year?

CSL has made 2.64 B USD this year.

How has the profit developed compared to last year?

The profit has increased by 20.42% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does CSL publish its earnings?

CSL publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of CSL?

The profits of CSL are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of CSL?

You can learn more about the earnings of CSL by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does CSL pay?

Over the past 12 months, CSL paid a dividend of 4 USD . This corresponds to a dividend yield of about 2 %. For the coming 12 months, CSL is expected to pay a dividend of 4.22 USD.

What is the dividend yield of CSL?

The current dividend yield of CSL is 2 %.

When does CSL pay dividends?

CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of CSL?

CSL paid dividends every year for the past 26 years.

What is the dividend of CSL?

For the upcoming 12 months, dividends amounting to 4.22 USD are expected. This corresponds to a dividend yield of 2.11 %.

In which sector is CSL located?

CSL is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSL from 10/2/2024 amounting to 2.203 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did CSL pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of CSL in the year 2023?

In the year 2023, CSL distributed 3.715 USD as dividends.

In which currency does CSL pay out the dividend?

The dividends of CSL are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The CSL stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von CSL

Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.